Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04238585 · ClinicalTrials.gov registry record · NA
BabyQ's: Randomized Controlled Trial of Health Messaging in Pregnancy and Infancy
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 291
- Enrollment target
NCT04238585: Completed NA study, sponsored by Columbia University.
NCT04238585 is a NA study that has completed, run by Columbia University. The registered enrollment target is 291 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04238585, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 291 participants
- Enrollment target
Study Summary
This randomized controlled intervention evaluates the effect of a mobile health behavioral intervention to test messages to reduce sugar-sweetened beverage intake during pregnancy and infancy. The study team will perform a prospective, longitudinal, interventional, randomized control trial by recruiting 300 WIC families during the first 1,000 days of life (pregnancy through infant age 2 months) at consecutive Women, Infants, and Children (WIC) visits to test two interventions compared to a control group. The study team will implement a mobile-based messaging intervention allocate participants to one of 3 arms for a 1 month period: 1) negative message frames, 2) positive message frames, and 3) attention control.
Primary Outcome
Determine change from baseline to follow-up in habitual daily caloric intake of SSBs using parent self report of beverage intake
Interventions
- BEHAVIORAL Mobile messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2020-01-27 |
| Est. Completion | 2021-02-17 |
| Phase | NA |
What the finished NCT04238585 record still lists
NCT04238585 is an interventional study that assigns participants to a tested intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile messaging is the first listed.
NCT04238585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04238585 about?
NCT04238585 is a clinical study titled "BabyQ's: Randomized Controlled Trial of Health Messaging in Pregnancy and Infancy". This randomized controlled intervention evaluates the effect of a mobile health behavioral intervention to test messages to reduce sugar-sweetened beverage intake during pregnancy and infancy. The study team will perform a prospective, longitudinal, interventional, randomized control trial by recru...
What is the current status of trial NCT04238585?
This trial is currently completed. It is a NA study. The enrollment target is 291 participants. The study started on 2020-01-27. Estimated completion is 2021-02-17.
What interventions are being tested in trial NCT04238585?
The interventions under investigation include: Mobile messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT04238585?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04238585's enrollment target sits among peer trials
291 375th of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02074839 · 291 participants · Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- NCT03769766 · 291 participants · Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- NCT06563479 · 291 participants · Phase 3
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI